Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm

Human Pathology

Volumn 44, Issue 9, 2013, Pages 1714-1721

  Morimatsu, Katsuya ^a   Aishima, Shinichi ^a   Yamamoto, Hidetaka ^a   Hayashi, Akifumi ^a   Nakata, Kohei ^a   Oda, Yasunori ^a   Shindo, Koji ^a   Fujino, Minoru ^a   Tanaka, Masao ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Diagnosis; IMP3; IPMN; Pancreas; Prognosis

Indexed keywords

INSULIN LIKE GROWTH FACTOR 2 MESSENGER RNA BINDING PROTEIN 3; RNA BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PANCREAS BIOPSY; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

DIAGNOSIS; IMP3; INSULIN-LIKE GROWTH FACTOR II MRNA-BINDING PROTEIN-3; INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM; IPMN; IPMN WITH AN ASSOCIATED INVASIVE CARCINOMA.; IPMN WITH HIGH-GRADE DYSPLASIA; IPMN WITH INTERMEDIATE-GRADE DYSPLASIA; IPMN WITH LOW-GRADE DYSPLASIA; IPMN-H; IPMN-I; IPMN-IC; IPMN-L; PANCREAS; PROGNOSIS;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; PANCREAS; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84883461184     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.12.020     Document Type: Article

References (35)

1. N.V. Adsay, N. Fukushima, and T. Furukawa Intraductal neoplasms of the pancreas F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumors of the digestive system 2010 IARC Press Lyon 304 313
2. R.H. Hruban, K. Takaori, and D.S. Klimstra An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
3. M. Tanaka, K. Kobayashi, K. Mizumoto, and K. Yamaguchi Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas J Gastroenterol 40 2005 669 675
4. F. Sessa, E. Solcia, and C. Capella Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients Virchows Arch 425 1994 357 367
5. M. Tanaka, S. Chari, and V. Adsay International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 2006 17 32
6. R. Salvia, C. Fernández-del Castillo, and C. Bassi Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection Ann Surg 239 2004 678 685
7. C.M. Schmidt, P.B. White, and J.A. Waters Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology Ann Surg 246 2007 644 651
8. M. Tanaka Controversies in the management of pancreatic IPMN Nat Rev Gastroenterol Hepatol 8 2011 56 60
9. J. Nielsen, J. Christiansen, J. Lykke-Andersen, A.H. Johnsen, U.M. Wewer, and F.C. Nielsen A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development Mol Cell Biol 19 1999 1262 1270
10. J. Nielsen, S.K. Adolph, and E. Rajpert-De Meyts Nuclear transit of human zipcode-binding protein IMP1 Biochem J 376 2003 383 391
11. F. Müeller-Pillasch, U. Lacher, and C. Wallrapp Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein Oncogene 14 1997 2729 2733
12. F. Mueller-Pillasch, B. Pohl, and M. Wilda Expression of the highly conserved RNA binding protein KOC in embryogenesis Mech Dev 88 1999 95 99
13. F.C. Nielsen, J. Nielsen, and J. Christiansen A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking Scand J Clin Lab Invest Suppl 234 2001 93 99
14. D.F. Schaeffer, D.R. Owen, and H.J. Lim Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival BMC Cancer 10 2010 59
15. D.L. Wachter, A. Schlabrakowski, J. Hoegel, G. Kristiansen, A. Hartmann, and M.O. Riener Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma Am J Surg Pathol 35 2011 873 877
16. Z. Jiang, P.G. Chu, and B.A. Woda Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study Lancet Oncol 7 2006 556 564
17. Y.M. Jeng, C.C. Chang, and F.C. Hu RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma Hepatology 48 2008 1118 1127
18. L. Li, H. Xu, and B.O. Spaulding Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors Hum Pathol 39 2008 1205 1211
19. L. Sitnikova, G. Mendese, and Q. Liu IMP3 predicts aggressive superficial urothelial carcinoma of the bladder Clin Cancer Res 14 2008 1701 1706
20. C. Li, V. Zota, and B.A. Woda Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations Mod Pathol 20 2007 1263 1268
21. W. Zheng, X. Yi, and O. Fadare The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma Am J Surg Pathol 32 2008 304 315
22. J.G. Pryor, P.A. Bourne, Q. Yang, B.O. Spaulding, G.A. Scott, and H. Xu IMP-3 is a novel progression marker in malignant melanoma Mod Pathol 21 2008 431 437
23. R.K. Yantiss, B.A. Woda, and G.R. Fanger KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas Am J Surg Pathol 29 2005 188 195
24. T. Furukawa, G. Klöppel, and N. Volkan Adsay Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study Virchows Arch 447 2005 794 799
25. R.L. King, T. Pasha, M.R. Roullet, P.J. Zhang, and A. Bagg IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue Hum Pathol 40 2009 1699 1705
26. D. Lu, X. Yang, and N.Y. Jiang IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer Am J Surg Pathol 35 2011 1638 1645
27. T. Terada, T. Ohta, Y. Kitamura, K. Ashida, and Y. Matsunaga Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study Arch Pathol Lab Med 122 1998 42 46
28. H. Zhao, D. Mandich, R.W. Cartun, and S. Ligato Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas Diagn Cytopathol 35 2007 700 704
29. T. Furukawa, T. Hatori, and I. Fujita Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas Gut 60 2011 509 516
30. Y. Masaki, M. Oka, and Y. Ogura Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma Hepatogastroenterology 46 1999 2240 2245
31. O. Walter, M. Prasad, S. Lu, R.M. Quinlan, K.L. Edmiston, and A. Khan IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype Hum Pathol 40 2009 1528 1533
32. H. Xu, P.A. Bourne, B.O. Spaulding, and H.L. Wang High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not Hum Pathol 38 2007 555 563
33. B. Liao, Y. Hu, D.J. Herrick, and G. Brewer The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells J Biol Chem 280 2005 18517 18524
34. J. Vikesaa, T.V. Hansen, and L. Jønson RNA-binding IMPs promote cell adhesion and invadopodia formation EMBO J 25 2006 1456 1468
35. J. Nemunaitis, T. Meyers, and N. Senzer Phase I trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer Mol Ther 13 2006 1185 1191